FDA

FDA. The Food and Drug Administration is a federal agency of the United States Department of Health and Human Services. It is responsible for protecting public health by ensuring the safety, efficacy, and security of a wide range of products, including human and veterinary drugs, biological products, medical devices, the nation's food supply, cosmetics, and products that emit radiation. The agency's work spans from pre-market evaluation to post-market surveillance, enforcing regulations established by laws such as the Federal Food, Drug, and Cosmetic Act.

History

The origins of the agency trace back to the late 19th century with the appointment of Harvey Washington Wiley, a chief chemist in the United States Department of Agriculture, who advocated for pure food laws. Public outrage following the publication of Upton Sinclair's novel The Jungle, which exposed unsanitary conditions in the meatpacking industry, was a pivotal catalyst. This led to the passage of the Pure Food and Drug Act of 1906, signed by President Theodore Roosevelt, which prohibited interstate commerce of misbranded and adulterated foods and drugs. A major tragedy, the Elixir Sulfanilamide incident of 1937, which caused over 100 deaths, prompted the comprehensive Federal Food, Drug, and Cosmetic Act of 1938, requiring proof of safety before marketing. Subsequent milestones include the Kefauver-Harris Amendments of 1962, enacted after the thalidomide tragedy, mandating proof of efficacy for drugs, and the formation of the Center for Drug Evaluation and Research in 1987.

Organization and structure

The agency is headed by a Commissioner, appointed by the President and confirmed by the United States Senate, with Robert Califf serving in that role. Its headquarters are located in White Oak, Maryland. The agency's operations are divided into several product-centric centers and offices, each with specialized expertise. Key centers include the Center for Biologics Evaluation and Research, the Center for Devices and Radiological Health, and the Center for Food Safety and Applied Nutrition. Other critical components are the Center for Veterinary Medicine, the Office of Regulatory Affairs, which conducts field inspections and enforcement, and the National Center for Toxicological Research. The agency also maintains numerous district offices across the country and works closely with other federal bodies like the Centers for Disease Control and Prevention and the United States Department of Agriculture.

Regulatory responsibilities

Its regulatory purview is extensive, covering the safety of most food products (except meat, poultry, and some egg products regulated by the United States Department of Agriculture), including dietary supplements and food additives. It regulates all prescription and over-the-counter drugs, ensuring their safety and effectiveness, as well as biological products like vaccines and blood transfusions. The agency oversees medical devices, from simple tongue depressors to complex technologies like pacemakers and artificial hearts. It also monitors the safety of cosmetics, products that emit radiation such as microwave ovens and X-ray machines, and regulates tobacco products under the Family Smoking Prevention and Tobacco Control Act. Enforcement tools include product recalls, warning letters, injunctions, and criminal prosecution.

Approval processes

For new drugs and biologics, sponsors must submit an Investigational New Drug application to begin human clinical trials, which typically proceed through Phase I, Phase II, and Phase III studies. Upon successful trials, a New Drug Application or Biologics License Application is submitted for review, with advisory committees like the Oncologic Drugs Advisory Committee often providing expert input. For medical devices, the pathway depends on risk; high-risk Class III devices generally require pre-market approval, while moderate-risk devices may qualify for the 510(k) clearance process. The Center for Food Safety and Applied Nutrition evaluates food additives and Generally recognized as safe substances. The agency also manages programs like the Prescription Drug User Fee Act, which provides funding for expedited reviews.

Criticisms and controversies

The agency has faced criticism for the perceived slow pace of the drug approval process, particularly during public health emergencies like the AIDS epidemic, which led to activist pressure and the creation of accelerated pathways. It has been scrutinized for its handling of specific drug safety issues, such as the withdrawal of Vioxx and controversies surrounding antidepressant use in adolescents. Its regulatory relationship with the industries it oversees sometimes raises concerns about regulatory capture and conflicts of interest. Debates continue over its authority and actions regarding plan B emergency contraception, medical cannabis, and the regulation of dietary supplements under the Dietary Supplement Health and Education Act of 1994. High-profile incidents, such as the peanut Corporation of America salmonella outbreak, have also prompted reviews of its food safety oversight capabilities.

Category:United States Department of Health and Human Services agencies Category:Food and Drug Administration Category:1906 establishments in the United States